Disruption of zinc transporter ZnT3 transcriptional activity and synaptic vesicular zinc in the brain of Huntington’s disease transgenic mouse

Abstract Background Huntington’s disease (HD) is a neurodegenerative disease that involves a complex combination of psychiatric, cognitive and motor impairments. Synaptic dysfunction has been implicated in HD pathogenesis. However, the mechanisms have not been clearly delineated. Synaptic vesicular...

Full description

Bibliographic Details
Main Authors: Li Niu, Li Li, Shiming Yang, Weixi Wang, Cuifang Ye, He Li
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Cell & Bioscience
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13578-020-00459-3
_version_ 1819051429565825024
author Li Niu
Li Li
Shiming Yang
Weixi Wang
Cuifang Ye
He Li
author_facet Li Niu
Li Li
Shiming Yang
Weixi Wang
Cuifang Ye
He Li
author_sort Li Niu
collection DOAJ
description Abstract Background Huntington’s disease (HD) is a neurodegenerative disease that involves a complex combination of psychiatric, cognitive and motor impairments. Synaptic dysfunction has been implicated in HD pathogenesis. However, the mechanisms have not been clearly delineated. Synaptic vesicular zinc is closely linked to modulating synaptic transmission and maintaining cognitive ability. It is significant to assess zinc homeostasis for further revealing the pathogenesis of synaptic dysfunction and cognitive impairment in HD. Results Histochemical staining by autometallography indicated that synaptic vesicular zinc was decreased in the hippocampus, cortex and striatum of N171-82Q HD transgenic mice. Analyses by immunohistochemistry, Western blot and RT-PCR found that the expression of zinc transporter 3 (ZnT3) required for transport of zinc into synaptic vesicles was obviously reduced in these three brain regions of the HD mice aged from 14 to 20 weeks  and  BHK  cells  expressing  mutant  huntingtin. Significantly, dual-luciferase reporter gene and chromatin immunoprecipitation assays demonstrated that transcription factor Sp1 could activate ZnT3 transcription via its binding to the GC boxes in ZnT3 promoter. Moreover, mutant huntingtin was found to inhibit the binding of Sp1 to the promoter of ZnT3 and down-regulate ZnT3 expression, and the decline in ZnT3 expression could be ameliorated through overexpression of Sp1. Conclusions This is first study to reveal a significant loss of synaptic vesicular zinc and a decline in ZnT3 transcriptional activity in the HD transgenic mice. Our work sheds a novel mechanistic insight into pathogenesis of HD that mutant huntingtin down-regulates expression of ZnT3 through inhibiting binding of Sp1 to the promoter of ZnT3 gene, causing disruption of synaptic vesicular zinc homeostasis. Disrupted vesicular zinc ultimately leads to early synaptic dysfunction and cognitive deficits in HD. It is also suggested that maintaining normal synaptic vesicular zinc concentration is a potential therapeutic strategy for HD.
first_indexed 2024-12-21T12:03:48Z
format Article
id doaj.art-8b9e02f2d18c41ef9ac457788948009a
institution Directory Open Access Journal
issn 2045-3701
language English
last_indexed 2024-12-21T12:03:48Z
publishDate 2020-09-01
publisher BMC
record_format Article
series Cell & Bioscience
spelling doaj.art-8b9e02f2d18c41ef9ac457788948009a2022-12-21T19:04:45ZengBMCCell & Bioscience2045-37012020-09-0110111310.1186/s13578-020-00459-3Disruption of zinc transporter ZnT3 transcriptional activity and synaptic vesicular zinc in the brain of Huntington’s disease transgenic mouseLi Niu0Li Li1Shiming Yang2Weixi Wang3Cuifang Ye4He Li5Department of Histology and Embryology, Tongji Medical College, Huazhong University of Science and TechnologySchool of Biomedical Sciences, LKS Faculty of Medicine, the University of Hong KongDepartment of Histology and Embryology, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Histology and Embryology, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Histology and Embryology, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Histology and Embryology, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Background Huntington’s disease (HD) is a neurodegenerative disease that involves a complex combination of psychiatric, cognitive and motor impairments. Synaptic dysfunction has been implicated in HD pathogenesis. However, the mechanisms have not been clearly delineated. Synaptic vesicular zinc is closely linked to modulating synaptic transmission and maintaining cognitive ability. It is significant to assess zinc homeostasis for further revealing the pathogenesis of synaptic dysfunction and cognitive impairment in HD. Results Histochemical staining by autometallography indicated that synaptic vesicular zinc was decreased in the hippocampus, cortex and striatum of N171-82Q HD transgenic mice. Analyses by immunohistochemistry, Western blot and RT-PCR found that the expression of zinc transporter 3 (ZnT3) required for transport of zinc into synaptic vesicles was obviously reduced in these three brain regions of the HD mice aged from 14 to 20 weeks  and  BHK  cells  expressing  mutant  huntingtin. Significantly, dual-luciferase reporter gene and chromatin immunoprecipitation assays demonstrated that transcription factor Sp1 could activate ZnT3 transcription via its binding to the GC boxes in ZnT3 promoter. Moreover, mutant huntingtin was found to inhibit the binding of Sp1 to the promoter of ZnT3 and down-regulate ZnT3 expression, and the decline in ZnT3 expression could be ameliorated through overexpression of Sp1. Conclusions This is first study to reveal a significant loss of synaptic vesicular zinc and a decline in ZnT3 transcriptional activity in the HD transgenic mice. Our work sheds a novel mechanistic insight into pathogenesis of HD that mutant huntingtin down-regulates expression of ZnT3 through inhibiting binding of Sp1 to the promoter of ZnT3 gene, causing disruption of synaptic vesicular zinc homeostasis. Disrupted vesicular zinc ultimately leads to early synaptic dysfunction and cognitive deficits in HD. It is also suggested that maintaining normal synaptic vesicular zinc concentration is a potential therapeutic strategy for HD.http://link.springer.com/article/10.1186/s13578-020-00459-3Synaptic vesicular zincZinc transporter 3Sp1Transcriptional inhibitionSynaptic dysfunctionHuntingtin
spellingShingle Li Niu
Li Li
Shiming Yang
Weixi Wang
Cuifang Ye
He Li
Disruption of zinc transporter ZnT3 transcriptional activity and synaptic vesicular zinc in the brain of Huntington’s disease transgenic mouse
Cell & Bioscience
Synaptic vesicular zinc
Zinc transporter 3
Sp1
Transcriptional inhibition
Synaptic dysfunction
Huntingtin
title Disruption of zinc transporter ZnT3 transcriptional activity and synaptic vesicular zinc in the brain of Huntington’s disease transgenic mouse
title_full Disruption of zinc transporter ZnT3 transcriptional activity and synaptic vesicular zinc in the brain of Huntington’s disease transgenic mouse
title_fullStr Disruption of zinc transporter ZnT3 transcriptional activity and synaptic vesicular zinc in the brain of Huntington’s disease transgenic mouse
title_full_unstemmed Disruption of zinc transporter ZnT3 transcriptional activity and synaptic vesicular zinc in the brain of Huntington’s disease transgenic mouse
title_short Disruption of zinc transporter ZnT3 transcriptional activity and synaptic vesicular zinc in the brain of Huntington’s disease transgenic mouse
title_sort disruption of zinc transporter znt3 transcriptional activity and synaptic vesicular zinc in the brain of huntington s disease transgenic mouse
topic Synaptic vesicular zinc
Zinc transporter 3
Sp1
Transcriptional inhibition
Synaptic dysfunction
Huntingtin
url http://link.springer.com/article/10.1186/s13578-020-00459-3
work_keys_str_mv AT liniu disruptionofzinctransporterznt3transcriptionalactivityandsynapticvesicularzincinthebrainofhuntingtonsdiseasetransgenicmouse
AT lili disruptionofzinctransporterznt3transcriptionalactivityandsynapticvesicularzincinthebrainofhuntingtonsdiseasetransgenicmouse
AT shimingyang disruptionofzinctransporterznt3transcriptionalactivityandsynapticvesicularzincinthebrainofhuntingtonsdiseasetransgenicmouse
AT weixiwang disruptionofzinctransporterznt3transcriptionalactivityandsynapticvesicularzincinthebrainofhuntingtonsdiseasetransgenicmouse
AT cuifangye disruptionofzinctransporterznt3transcriptionalactivityandsynapticvesicularzincinthebrainofhuntingtonsdiseasetransgenicmouse
AT heli disruptionofzinctransporterznt3transcriptionalactivityandsynapticvesicularzincinthebrainofhuntingtonsdiseasetransgenicmouse